Biotech Fundraising in a Downturn
Denunciar
Compartilhar
•0 gostou•111 visualizações
Biotech Fundraising in a Downturn
•0 gostou•111 visualizações
Denunciar
Compartilhar
Baixar para ler offline
A few slides from my "investor spotlight" talk at BioCap 2023 at Alderley Park on 28/09/2023, shining a light on some things that improve a biotech startup's chances of successfully raising funding even in difficult times.
Mais conteúdo relacionado
Similar a Biotech Fundraising in a Downturn
Similar a Biotech Fundraising in a Downturn(20)
Mais de Volker Hirsch
Mais de Volker Hirsch(20)
Último
Último(20)
Biotech Fundraising in a Downturn
- 1. Volker Hirsch CCO Medicines Discovery Catapult / Venture Partner Amadeus Capital NavigatingDifficultTimes Fundraising in a downturn @vhirsch
- 4. Grim Reading The macro-economic situation affects the whole value chain Fund investors Venture Capital Funds Startups Alternatives in high-interest environment with less risk Tougher fundraising environment, protection of portfolio, capital preservation Less available and more risk-averse capital, inflation reduces runway
- 6. Focus On What You Can control
- 7. Back to study! You need to come prepared!
- 8. Science!
- 10. Exhibit 1: a typical biotech pitch deck
- 13. Main ingredient 1 Who do you speak to? (Preferably not to a room of AI-generated “business people”)
- 14. Main ingredient 2 What do you tell them?
- 15. Identifying Value inflection points Sign-posting exit ramps
- 16. Thank You! @vhirsch me@vhirsch.com +44 7843 599 678 https://md.catapult.org.uk